Status:
COMPLETED
Efficacy and Safety of Ivabradine in Severe Congestive Heart Failure
Lead Sponsor:
Institut de Recherches Internationales Servier
Conditions:
Heart Failure, Congestive
Eligibility:
All Genders
18-75 years
Phase:
PHASE2
Brief Summary
To evaluate the effects on heart function of ivabradine administered to patients with severe chronic heart failure
Eligibility Criteria
Inclusion
- systolic congestive heart failure
- sinus rhythm, HR \>= 80bpm
Exclusion
- unstable cardiovascular condition
Key Trial Info
Start Date :
September 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2006
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT00202579
Start Date
September 1 2004
End Date
February 1 2006
Last Update
July 25 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Policlinico San Matteo
Pavia, Italy, 27100